Lactose (India) Ltd. (BSE: 524202) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹132 Cr, it ranks #3,005 by market cap among the 6,197 Indian listed companies on FinBizNet, and #64 of 86 in Medicinal Chemicals and Botanical Products. At ₹106.00 (as of 16 Nov 2026), the share price is 22.3% below its 52-week high of ₹136.45 and 39.5% above its 52-week low of ₹76.01. The share price is down 7.8% over one year and down 1.1% over three months.
| Current Price | ₹106.00 |
|---|---|
| Market Cap | ₹132 Cr |
| BSE Code | 524202 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 22.2 |
| Return on Equity | 9.82% |
| Return on Assets | 5.00% |
| 52-Week Range | ₹76.01 – ₹136.45 |
| 1-Year Price Change | -7.8% |
| 3-Month Price Change | -1.1% |
| Beta (1Y) | 0.26 |
| Headquarters | Mumbai, Maharashtra |
| Website | www.lactoseindialimited.com |
Delivery averaged 78.0% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India and internationally. The company offers lactose monohydrate; solid dosage forms comprising dry granulated, film, and lacquer coated tablets, as well as uncoated and blister packed solid dose forms; and liquid dosage forms. It also provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as well as for use as a prebiotic. In addition, the company exports its products. Lactose (India) Limited was incorporated in 1991 and is headquartered in Mumbai, India.
1. Pharmaceuticals-This segment manufactures and trades in pharmaceutical products. 2. Segment Adjustment-This segment offers textile products. 3. Project Export-0 4. Textile-0
1. Manufacturing & Trading of Pharmaceutical Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,56,425 Cr | 39.5 | 14.72% | ₹16,199 Cr | +11.2% |
| Laurus Labs Ltd | ₹1,31,242 Cr | 145.6 | 17.74% | ₹2,206 Cr | +146.8% |
| Zydus Lifesciences Ltd | ₹1,19,651 Cr | 24.1 | 18.32% | ₹7,910 Cr | +26.0% |
| Dr.Reddys Lab | ₹1,15,464 Cr | 26.9 | 11.52% | ₹8,698 Cr | +14.5% |
| Cipla Limited | ₹1,14,712 Cr | 29.3 | 11.74% | ₹7,404 Cr | -7.6% |
| Mankind Pharma | ₹1,09,870 Cr | 57 | 12.45% | ₹4,338 Cr | +16.7% |
| Aurobindo Pharma Ltd. | ₹1,05,150 Cr | 30 | 9.93% | ₹10,263 Cr | +59.8% |
| Lupin Ltd | ₹92,087 Cr | 17.3 | 26.91% | ₹7,827 Cr | +0.4% |
| Lactose (India) Ltd. | ₹132 Cr | 22.2 | 9.82% | — | -7.8% |
Listed by market capitalisation. Ratios are shown for context only.
Lactose (India) Ltd. is trading at ₹106.00, with a market capitalisation of ₹132 Cr.
Lactose (India) Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Lactose (India) Ltd. has a P/E of 22.2 and a return on equity of 9.82%.
Lactose (India) Ltd. is listed on the BSE under the scrip code 524202.
Lactose (India) Ltd.'s share price is down 7.8% over one year and down 1.1% over three months. Its 52-week range is ₹76.01 to ₹136.45.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.